We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$39.9B
AUM Growth
+$4.88B
(+14%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
7.63%
Holding
3,452
New
521
Increased
1,149
Reduced
1,091
Closed
479
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$332M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$309M |
| 3 |
Nike
NKE
|
+$252M |
| 4 |
NVIDIA
NVDA
|
+$209M |
| 5 |
Target
TGT
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$238M |
| 2 |
PCGU
PG&E Corporation
PCGU
|
+$218M |
| 3 |
ConocoPhillips
COP
|
+$185M |
| 4 |
Amazon
AMZN
|
+$165M |
| 5 |
Cigna
CI
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.77% |
| 2 | Healthcare | 13.85% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.2% |
| 5 | Financials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Lipocine
LPCN
$17.6M
| $55.6K | ﹤0.01% |
11,033
-3,907
| -26% | -$18.4K |
|
2777
Hyperfine
HYPR
$94.8M
| $55.2K | ﹤0.01% |
25,678
-62,914
| -71% | -$103K |
|
|
IVA
2778
Inventiva
IVA
$1.13B
| $55K | ﹤0.01% |
+13,608
| New | +$45K |
|
|
UBX
2779
DELISTED
Unity Biotechnology
UBX
| $54.8K | ﹤0.01% |
21,500
+1,900
| +10% | +$5.02K |
|
2780
Newegg Commerce
NEGG
$359M
| $54.4K | ﹤0.01% |
2,323
+1,458
| +169% | +$32.9K |
|
|
MKFG
2781
DELISTED
Markforged Holding Corporation
MKFG
| $54.3K | ﹤0.01% |
+4,491
| New | +$42.3K |
|
|
IMMP
2782
Immutep
IMMP
$56.9M
| $54.1K | ﹤0.01% |
+25,646
| New | +$48K |
|
|
AKTS
2783
DELISTED
Akoustis Technologies Inc
AKTS
| $52.2K | ﹤0.01% |
16,411
-86,423
| -84% | -$265K |
|
2784
Douglas Elliman
DOUG
$162M
| $52.1K | ﹤0.01% |
+23,480
| New | +$64.5K |
|
|
CELL
2785
DELISTED
PhenomeX Inc. Common Stock
CELL
| $51.6K | ﹤0.01% |
+105,302
| New | +$86.1K |
|
2786
Palladyne AI
PDYN
$296M
| $51.4K | ﹤0.01% |
26,653
-9,004
| -25% | -$21.5K |
|
2787
Cue Biopharma
CUE
$114M
| $51.4K | ﹤0.01% |
+469
| New | +$55.1K |
|
2788
Hycroft Mining Holding Corp
HYMC
$2.47B
| $51.1K | ﹤0.01% |
+17,291
| New | +$65.5K |
|
|
GNFT
2789
DELISTED
Genfit
GNFT
| $50.9K | ﹤0.01% |
14,365
-7,000
| -33% | -$28.9K |
|
2790
Werewolf Therapeutics
HOWL
$19.3M
| $50.4K | ﹤0.01% |
16,537
-9,300
| -36% | -$26.2K |
|
2791
Cadiz
CDZI
$291M
| $50.3K | ﹤0.01% |
+12,400
| New | +$54.8K |
|
2792
Century Therapeutics
IPSC
$361M
| $50.1K | ﹤0.01% |
15,864
-21,354
| -57% | -$68.8K |
|
|
TEAD
2793
Teads Holding Co
TEAD
$66.9M
| $50.1K | ﹤0.01% |
+10,182
| New | +$44.8K |
|
2794
Mangoceuticals
MGRX
$8.45M
| $49.6K | ﹤0.01% |
+1,807
| New | +$35.6K |
|
|
EMBK
2795
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $49.2K | ﹤0.01% |
+17,200
| New | +$48.1K |
|
2796
Cumberland Pharmaceuticals
CPIX
$117M
| $48.8K | ﹤0.01% |
33,230
-200
| -0.6% | -$345 |
|
2797
Talkspace
TALK
$874M
| $46.9K | ﹤0.01% |
36,900
-13,700
| -27% | -$13.3K |
|
2798
Citius Pharmaceuticals
CTXR
$18.7M
| $46.8K | ﹤0.01% |
+1,561
| New | +$51.4K |
|
2799
Precision BioSciences
DTIL
$207M
| $46.2K | ﹤0.01% |
2,929
+2,506
| +592% | +$57.3K |
|
2800
Dominari Holdings
DOMH
$55.4M
| $45.9K | ﹤0.01% |
15,779
-1,800
| -10% | -$5.44K |
|
Similar funds
VAM
Two Sigma Investments's Q2 2023 Portfolio in Review
As of Q2 2023, Two Sigma Investments held 3,452 positions worth $39.9B, up 14% from $35B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
Two Sigma Investments deployed $2.46B of net new capital in Q2 2023, opening 521 new positions and adding to 1,149 existing holdings. Its largest new stake was Nike: 2,150,643 shares worth $237M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Netflix, an estimated $238M trimmed.
- Two Sigma Investments's largest Q2 2023 buy was Nike: 2,150,643 shares worth $237M.
- Two Sigma Investments added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $332M increase.
- Two Sigma Investments's biggest Q2 2023 reduction was Netflix, cutting an estimated $238M.
- Two Sigma Investments fully exited Goldman Sachs in Q2 2023, selling an estimated $127M.
- Two Sigma Investments's ten largest holdings make up 7.6% of its $39.9B portfolio in Q2 2023.
- Two Sigma Investments opened 521 new positions and closed 479 in Q2 2023.
- Two Sigma Investments's portfolio value rose 14% quarter-over-quarter to $39.9B.
Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.